CN104288707A - Traditional Chinese medicinal composition for treating pelvic inflammation - Google Patents

Traditional Chinese medicinal composition for treating pelvic inflammation Download PDF

Info

Publication number
CN104288707A
CN104288707A CN201410623266.1A CN201410623266A CN104288707A CN 104288707 A CN104288707 A CN 104288707A CN 201410623266 A CN201410623266 A CN 201410623266A CN 104288707 A CN104288707 A CN 104288707A
Authority
CN
China
Prior art keywords
parts
rhizoma
traditional chinese
chinese medicinal
medicinal composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410623266.1A
Other languages
Chinese (zh)
Inventor
王新波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410623266.1A priority Critical patent/CN104288707A/en
Publication of CN104288707A publication Critical patent/CN104288707A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/86—Violaceae (Violet family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994—Coix (Job's tears)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/902—Sparganiaceae (Bur-reed family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine, and particularly discloses a traditional Chinese medicinal composition for treating pelvic inflammation. The traditional Chinese medicinal composition is characterized by being prepared from the following raw materials in parts by weight: 10-15 parts of polygonum aviculare, 10-15 parts of dianthus superbus, 6-9 parts of akebiaquinata, 9-12 parts of semen plantaginis, 10-15 parts of talcum, 9-12 parts of rhizoma corydalis, 10-15 parts of fructus forsythiae, 10-20 parts of dandelion, 10-20 parts of herba violae, 3-6 parts of rheum officinale, 6-9 parts of golden cypress, 6-9 parts of szechwan chinaberry fruit, 3-6 parts of rhizoma sparganii, 3-6 parts of curcuma zedoary, 3-6 parts of pangolin, 6-9 parts of rhizoma smilacis glabrae and 10-20 parts of semen coicis. The traditional Chinese medicinal composition improves symptoms by clearing away heat and removing dampness, removing stasis and stopping pains, and inducing diuresis for treating strangurtia so as to achieve the effect of treating the pelvic inflammation, with a significant therapeutic effect, thereby improving the life quality of a patient; the traditional Chinese medicinal composition is good in therapeutic effect, quick in effect and free of side effects and has the effective rate of 98%.

Description

A kind of Chinese medicine composition for the treatment of pelvic inflammatory disease
Technical field
The present invention relates generally to the field of Chinese medicines, particularly relates to a kind of Chinese medicine for the treatment of pelvic inflammatory disease.
Background technology
Pelvic inflammatory disease means the inflammatory lesion that women's internal reproductive organ and surrounding connective tissue and pelvic peritoneum thereof occur, and being the common cause causing pelvic pain, is also one of factor affecting healthy reproduction.How being transformed by acute pelvic inflammatory disease, its sickness rate has rising trend in recent years, and primary disease predisposing factors is complicated, and the state of an illness is obstinate, and easy recurrent exerbation is bad during symptom fashion, has a strong impact on physical and mental health and the work of patient.Pelvic inflammatory disease belongs to the categories such as Chinese medicine women stomachache, leukorrhagia, menoxenia, lump in the abdomen, receive accidentally owing to taking the photograph after gynecologic menstrual, puerperal or wound, being invaded by exogenous pathogen so that vessels of the uterus are obstructed qi-blood disharmony, if treat not in time, not thoroughly or wrong treatment, with the passing of time delay forms again.
The medicine of current treatment pelvic inflammatory disease, doctor trained in Western medicine, substantially based on antibiotic therapy, needs long-term prescription, and side effect great Yi produces toleration, cures the symptoms, not the disease, and easily repeatedly, therapeutic effect is undesirable.Traditional Chinese Medicine emphasizes the advantages such as organic conception, regulating yin and yang, treating both the principal and secondary aspects of a disease, toxic and side effects are little owing to having, and is more and more approved by people.
Summary of the invention
The object of the invention is exactly the defect in order to make up prior art, provides a kind of Chinese medicine composition of special for treating pelvic inflammatory disease, and it is obvious for treatment pelvic inflammatory disease curative effect, and safe ready, side effect is little.
The present invention is achieved by the following technical solutions:
Treat a Chinese medicine composition for pelvic inflammatory disease, it is characterized in that: the weight proportion of each raw material is: Herba Polygoni Avicularis 10-15, Herba Dianthi 10-15, Caulis Akebiae 6-9, Semen Plantaginis 9-12, Talcum 10-15, Rhizoma Corydalis 9-12, Fructus Forsythiae 10-15, Herba Taraxaci 10-20, Herba Violae 10-20, Radix Et Rhizoma Rhei 3-6, Cortex Phellodendri 6-9, Fructus Toosendan 6-9, Rhizoma Sparganii 3-6, Rhizoma Curcumae 3-6, Squama Manis 3-6, Rhizoma Smilacis Glabrae 6-9, Semen Coicis 10-20.
Treat a Chinese medicine composition for pelvic inflammatory disease, it is preferably: the weight proportion of each raw material is: Herba Polygoni Avicularis 12, Herba Dianthi 12, Caulis Akebiae 8, Semen Plantaginis 10, Talcum 12, Rhizoma Corydalis 10, Fructus Forsythiae 12, Herba Taraxaci 15, Herba Violae 15, Radix Et Rhizoma Rhei 5, Cortex Phellodendri 8, Fructus Toosendan 8, Rhizoma Sparganii 5, Rhizoma Curcumae 5, Squama Manis 4, Rhizoma Smilacis Glabrae 8, Semen Coicis 15.
Compound method of the present invention is as follows: medicinal cold water soak in above-mentioned decocted after 1 hour, decocts moisture content and exceedes Chinese medicine 2-3 centimetre, with slow fire boiling 50 minutes after water boiling, filters and pours out medicinal liquid.Divide sooner or later, twice on the one.
detailed description of the invention:
Treat a Chinese medicine composition for pelvic inflammatory disease, it is preferably: the weight proportion of each raw material is: Herba Polygoni Avicularis 12g, Herba Dianthi 12g, Caulis Akebiae 8g, Semen Plantaginis 10g, Talcum 12g, Rhizoma Corydalis 10g, Fructus Forsythiae 12g, Herba Taraxaci 15g, Herba Violae 15g, Radix Et Rhizoma Rhei 5g, Cortex Phellodendri 8g, Fructus Toosendan 8g, Rhizoma Sparganii 5g, Rhizoma Curcumae 5g, Squama Manis 4g, Rhizoma Smilacis Glabrae 8g, Semen Coicis 15g.
Take the raw material components of above correspondence group, according to the routine fashion of decoction, add water and boil decoction and take.Divide sooner or later, twice on the one.
clinical observation:
Physical data:
(1) efficacy assessment standard:
Efficacy assessment standard is formulated with reference to " new Chinese medicine guideline of clinical investigations " (version in 2002) " guideline of clinical investigations of new Chinese medicine treatment pelvic inflammatory disease ":
Cure: the diseases such as hypogastralgia and waist sacrum distending pain disappear, normally, drug withdrawal is not recurred in January for gynecologial examination and physico-chemical examination.
Effective: the diseases such as hypogastralgia and waist sacrum distending pain disappear or obviously alleviate, and gynecologial examination and physico-chemical examination obviously improve.
Effective: the diseases such as hypogastralgia and waist sacrum distending pain alleviate, and gynecologial examination and physico-chemical examination make moderate progress.
Invalid: symptom, sign increase the weight of without alleviating or having, gynecologial examination and physico-chemical examination increase the weight of without improving or having before comparatively treating.
The present inventor, year May in May, 2012 to 2014, carries out clinical observation treatment to 100 routine patients.Pelvic inflammatory disease is diagnosed as according to " new Chinese medicine guideline of clinical investigations " (China Medical Science Press, 2002).Wherein severe person 6 example, moderate person 26 example, slight person 68 example.
(2) Therapeutic Method:
With medicine soak by water taking liquid of the present invention, within 1 month, be a course for the treatment of, medical treatment continues 2-3 the course for the treatment of, with consolidate curative effect.
(3) therapeutic effect:
?clinical cure 69 example, effective 22 examples, effective 7 examples, invalid 2 examples, all cases all have no adverse reaction.
(4) sum up: effective percentage 98%, cure rate 69%.
The present invention is by removing damp-heat, and blood-activating analgetic, inducing diuresis for treating stranguria syndrome, improves symptom, reaches the effect for the treatment of pelvic inflammatory disease.Fang Zhong Herba Polygoni Avicularis, Herba Dianthi, Caulis Akebiae, Semen Plantaginis, enter urinary bladder channel, clearing away damp-heat from lower-JIAO, causes the puckery pain person of dribbling urination for damp invasion of lower energizer in bladder; Talcum, inducing diuresis for treating stranguria syndrome, clearing away summer-heat, removing dampness sore; Rhizoma Corydalis, blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, in Compendium of Material Medica, note has: " invigorating blood circulation, promoting the circulation of QI, pain relieving, diuresis " four large effects; Fructus Forsythiae, Herba Taraxaci, Herba Violae, heat-clearing and toxic substances removing, dispersing swelling and dissipating binds; Radix Et Rhizoma Rhei, Cortex Phellodendri, removing damp-heat, removing toxicity for eliminating carbuncles, clots absorbing stimulate the menstrual flow; Fructus Toosendan, catharsis liver-heat, promoting the circulation of QI to relieve pain, control the stagnation of QI and have the card of heat especially suitable; Rhizoma Sparganii, Rhizoma Curcumae, promoting the circulation of QI to relieve pain, removing blood stasis removing food stagnancy, for the amenorrhea of qi depression to blood stasis, chest and hypochondrium, stomachache and lump in the abdomen lump etc.; Squama Manis, blood circulation promoting and dispersing pathogen accumulation, eliminating carbuncle are burst hard, main blood stasis amenorrhea, lump in the abdomen; Rhizoma Smilacis Glabrae, dampness removing reduces phlegm and internal heat, and can enter network, searches to pick and damp and hot accumulates poison; Semen Coicis, spleen invigorating eliminating dampness by diuresis, eliminating impediment antidiarrheal, for sandstone pyretic stranguria.It is evident in efficacy, significantly reduces patient suffering, and relapse rate obviously declines, and improves the quality of life of patient, and has no side effect, and patient can feel at ease to take.Chinese medicine of the present invention, good effect, instant effect, has no side effect, and effective percentage reaches 98%.
For proving that the present invention has good curative effect, enumerate model case as follows:
Case 1.
Wang, female is 26 years old, married.Within 8th, go to a doctor in JIUYUE in 2013.Patient moves ahead after artificial abortion half a year, and within postoperative 12 days, lower abdomen is sad, and profuse leukorrhea yellow skin frowziness, with fever.Cure 3 days through doctor trained in Western medicine antibiotic, fever is moved back, but still tells lower abdomen dull pain falling inflation, lumbosacral aching pain, profuse leukorrhea yellow skin.Red tongue, yellow fur, stringy and thready pulse.B ultrasonic is detected and is manifested: right side is visited and 5cm × 7cm × 3cm size enclosed mass, reminds inflammatory masses of pelvic cavity, and accompanies pelvic hydrops.Be diagnosed as chronic pelvic inflammatory enclosed mass, Chinese medical discrimination is damp and hot silt resistance type, uses Chinese medicine of the present invention to take 3 courses for the treatment of continuously, and all diseases disappear, and gynecological and ultrasound diagnosis are all normal.Within 1 year, do not recur with anti-.
Case 2.
Liu, female, 34 years old, once suffered from acute pelvic inflammatory disease before 2 years, take a turn for the better after doctor trained in Western medicine antibiotic is cured, but thorough turn for the treatment of leads to chronic, usually sagging distention in the smaller abdomen is uncomfortable, profuse leukorrhea yellow skin, dark menses block, discomfort of urinating, yellow urine, constipation, red tip of the tongue, while there is petechia, wiry and frequent pulse, often after intercourse, increases the weight of before and after menstruation, once applied Multiple Classes of Antibiotics medicine, but produced little effect, and usually repeated to occur.B ultrasonic is reminded: both sides, uterus adnexa all thickens, and left side is comparatively nervous, and with pelvic hydrops.Western medicine diagnose: chronic pelvic inflammatory disease.Use Chinese medicine of the present invention to take 1 course for the treatment of continuously, symptom is clearly better, and continues and takes 1 course for the treatment of, without uncomfortable sensation, therefore drug withdrawal.

Claims (2)

1. treat a Chinese medicine composition for pelvic inflammatory disease, it is characterized in that: the weight proportion of each raw material is: Herba Polygoni Avicularis 10-15, Herba Dianthi 10-15, Caulis Akebiae 6-9, Semen Plantaginis 9-12, Talcum 10-15, Rhizoma Corydalis 9-12, Fructus Forsythiae 10-15, Herba Taraxaci 10-20, Herba Violae 10-20, Radix Et Rhizoma Rhei 3-6, Cortex Phellodendri 6-9, Fructus Toosendan 6-9, Rhizoma Sparganii 3-6, Rhizoma Curcumae 3-6, Squama Manis 3-6, Rhizoma Smilacis Glabrae 6-9, Semen Coicis 10-20.
2. Chinese medicine composition as claimed in claim 1, is characterized in that: the weight proportion of each raw material is: Herba Polygoni Avicularis 12, Herba Dianthi 12, Caulis Akebiae 8, Semen Plantaginis 10, Talcum 12, Rhizoma Corydalis 10, Fructus Forsythiae 12, Herba Taraxaci 15, Herba Violae 15, Radix Et Rhizoma Rhei 5, Cortex Phellodendri 8, Fructus Toosendan 8, Rhizoma Sparganii 5, Rhizoma Curcumae 5, Squama Manis 4, Rhizoma Smilacis Glabrae 8, Semen Coicis 15.
CN201410623266.1A 2014-11-09 2014-11-09 Traditional Chinese medicinal composition for treating pelvic inflammation Pending CN104288707A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410623266.1A CN104288707A (en) 2014-11-09 2014-11-09 Traditional Chinese medicinal composition for treating pelvic inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410623266.1A CN104288707A (en) 2014-11-09 2014-11-09 Traditional Chinese medicinal composition for treating pelvic inflammation

Publications (1)

Publication Number Publication Date
CN104288707A true CN104288707A (en) 2015-01-21

Family

ID=52308818

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410623266.1A Pending CN104288707A (en) 2014-11-09 2014-11-09 Traditional Chinese medicinal composition for treating pelvic inflammation

Country Status (1)

Country Link
CN (1) CN104288707A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105770625A (en) * 2016-04-24 2016-07-20 张昌莲 Traditional Chinese medicine composition for treating pelvic inflammation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101700326A (en) * 2009-09-11 2010-05-05 陕西东泰制药有限公司 Preparation method of traditional Chinese medicine preparation for clearing heat and promoting urination for treating stranguria
CN102058847A (en) * 2010-12-16 2011-05-18 赵翠英 Chinese medicine composition for treating pelvic cavity diseases as well as preparation method and application thereof
CN103536888A (en) * 2013-10-31 2014-01-29 金占荣 Medicine for treating chronic pelvic inflammation and preparation method of same
CN103550308A (en) * 2013-09-30 2014-02-05 赵丰隆 Traditional Chinese medicine formula for treatment of chronic pelvic inflammation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101700326A (en) * 2009-09-11 2010-05-05 陕西东泰制药有限公司 Preparation method of traditional Chinese medicine preparation for clearing heat and promoting urination for treating stranguria
CN102058847A (en) * 2010-12-16 2011-05-18 赵翠英 Chinese medicine composition for treating pelvic cavity diseases as well as preparation method and application thereof
CN103550308A (en) * 2013-09-30 2014-02-05 赵丰隆 Traditional Chinese medicine formula for treatment of chronic pelvic inflammation
CN103536888A (en) * 2013-10-31 2014-01-29 金占荣 Medicine for treating chronic pelvic inflammation and preparation method of same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王岳明: "辨证治疗慢性盆腔炎65例", 《浙江中医药大学学报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105770625A (en) * 2016-04-24 2016-07-20 张昌莲 Traditional Chinese medicine composition for treating pelvic inflammation

Similar Documents

Publication Publication Date Title
CN102940721B (en) Medicine for treating chronic pelvic inflammation
CN102579897A (en) Medicine for treating postoperative uroschesis of anorectal diseases and preparation method thereof
CN101428106B (en) Medicament composition for treating female infertility, and uses thereof
CN103585586B (en) A kind of Chinese medicine composition for the treatment of hysteromyoma and preparation method thereof
CN104043022A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN102973677B (en) Traditional Chinese medicine for treating ovarian cyst
CN112022916A (en) Traditional Chinese medicine composition and preparation for treating postpartum body pain and preparation method and application thereof
CN105031331B (en) A kind of navel patch and preparation method thereof for treating dysmenorrhea
CN103083616B (en) Traditional Chinese medicine for treating ovarian cyst
CN112807411A (en) External traditional Chinese medicine composition with functions of relaxing tendons and activating collaterals, hot compress medicine bag and external traditional Chinese medicine preparation
CN103083617B (en) Traditional Chinese medicine for treating hyperplasia of prostate
CN104998232A (en) Dysmenorrhea patch
CN104721758A (en) Pharmaceutical for treating ovarian cyst and preparing method thereof
CN104288707A (en) Traditional Chinese medicinal composition for treating pelvic inflammation
CN101780257B (en) Traditional Chinese medicine for treating rheumatoid arthritis
CN106389557B (en) A kind of Chinese medicine composition and its preparation method and application for Chinese medicine moxibustion
CN104173982B (en) Medicine for treating pelvic inflammation and preparation method
CN104173610B (en) Traditional Chinese medicine preparation for treating pelvic inflammatory disease and preparation method thereof
CN103494991B (en) Traditional Chinese medicine preparation for treating female metrorrhagia and preparation method thereof
CN103142710B (en) Chinese medicinal composition for treating chronic prostatitis
CN105232864A (en) Traditional Chinese medicine clysis preparation for treating qi stagnation and blood stasis endometriosis
CN105412837A (en) Medicine for treating prostatic hyperplasia
CN101371912A (en) Chinese medicine oral decoction for treating dysmenorrhea
CN105770753A (en) Traditional Chinese medicine composition for treating extrauterine pregnancy
CN105943644A (en) Traditional Chinese medicine moxibustion composition for lumbar muscle degeneration and preparation method and application of traditional Chinese medicine moxibustion composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150121